Sign in

CIK 0001676725

  • Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474268251
Phone
+1 650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$985,397
in 1 filing, $985K under 10b5-1 plans

Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hata Yujiro S −$985K President and CEO sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2020-06-16 Lackner Mark SVP, Head of Biology Exercise or conversion +3,887 $4.62 $18K 3,887
2020-06-16 Lackner Mark SVP, Head of Biology Exercise or conversion +2,863 $6.98 $20K 6,750
2020-06-16 Lackner Mark SVP, Head of Biology Sale −6,750 $14.93 $101K 0
2020-06-16 Lackner Mark SVP, Head of Biology Exercise or conversion · Stock Option (right to buy) −3,887 62,510
2020-06-16 Lackner Mark SVP, Head of Biology Exercise or conversion · Stock Option (right to buy) −2,863 36,137
2020-06-02 Lackner Mark SVP, Head of Biology Sale −408 $8.55 $3K 437
2020-06-02 Lackner Mark SVP, Head of Biology Sale −333 $9.73 $3K 104
2020-06-02 Lackner Mark SVP, Head of Biology Sale −104 $10.11 $1K 0
2020-02-21 Lackner Mark SVP, Head of Biology Grant or award · Stock Option (right to buy) +40,000 40,000

Page 2 of 2 · 29 trades